Investing.com - GlaxoSmithKline reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
GlaxoSmithKline announced earnings per share of £0.328 on revenue of £9.78B. Analysts polled by Investing.com anticipated EPS of £0.2902 on revenue of £8.95B.
GlaxoSmithKline shares are up 10.77% from the beginning of the year and are trading at £1,779.60 , down-from-52-week-high.They are outperforming the TR UK 50 which is up 3.36% from the start of the year.
GlaxoSmithKline shares gained 1.43% in intra-day trade the report.
GlaxoSmithKline follows other major Healthcare sector earnings this month
GlaxoSmithKline's report follows an earnings missed by Oxford BioMedica on April 20, who reported EPS of £0.01 on revenue of £61.55M, compared to forecasts EPS of £7.80 on revenue of £77.28M.
EKF Diagnostics had missed expectations on March 29 with first quarter EPS of £0.01 on revenue of £43.28M, compared to forecast for EPS of £2.19 on revenue of £42.45M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar